Citation: | Brianna Lide, Shane McGuire, Hong Liu, Cristina Chandler. Mast cell activation syndrome—anesthetic challenges in two different clinical scenarios[J]. The Journal of Biomedical Research. doi: 10.7555/JBR.36.20220071 |
[1] |
Weiler CR, Austen KF, Akin C, et al. AAAAI Mast Cell Disorders Committee Work Group Report: mast cell activation syndrome (MCAS) diagnosis and management[J]. J Allergy Clin Immunol, 2019, 144(4): 883–896. doi: 10.1016/j.jaci.2019.08.023
|
[2] |
Valent P, Akin C, Arock M, et al. Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal[J]. Int Arch Allergy Immunol, 2012, 157(3): 215–225. doi: 10.1159/000328760
|
[3] |
Valent P, Akin C, Nedoszytko B, et al. Diagnosis, classification and management of mast cell activation syndromes (MCAS) in the era of personalized medicine[J]. Int J Mol Sci, 2020, 21(23): 9030. doi: 10.3390/ijms21239030
|
[4] |
Petra AI, Panagiotidou S, Stewart JM, et al. Spectrum of mast cell activation disorders[J]. Expert Rev Clin Immunol, 2014, 10(6): 729–739. doi: 10.1586/1744666X.2014.906302
|
[5] |
Bonadonna P, Pagani M, Aberer W, et al. Drug hypersensitivity in clonal mast cell disorders: ENDA/EAACI position paper[J]. Allergy, 2015, 70(7): 755–763. doi: 10.1111/all.12617
|
[6] |
Di Leo E, Donne PD, Calogiuri GF, et al. Focus on the agents most frequently responsible for perioperative anaphylaxis[J]. Clin Mol Allergy, 2018, 16: 16. doi: 10.1186/s12948-018-0094-7
|
[7] |
Blunk JA, Schmelz M, Zeck S, et al. Opioid-induced mast cell activation and vascular responses is not mediated by mu-opioid receptors: an in vivo microdialysis study in human skin[J]. Anesth Analg, 2004, 98(2): 364–370. doi: 10.1213/01.ANE.0000097168.32472.0D
|
[8] |
Matito A, Morgado JM, Sánchez-López P, et al. Management of anesthesia in adult and pediatric mastocytosis: a study of the spanish network on mastocytosis (REMA) based on 726 anesthetic procedures[J]. Int Arch Allergy Immunol, 2015, 167(1): 47–56. doi: 10.1159/000436969
|
[9] |
By the 2019 American Geriatrics Society Beers Criteria® Update Expert Panel. American geriatrics society 2019 updated AGS beers criteria® for potentially inappropriate medication use in older adults[J]. J Am Geriatr Soc, 2019, 67(4): 674–694. doi: 10.1111/jgs.15767
|
[10] |
Hermans MAW, Arends NJT, van Wijk RG, et al. Management around invasive procedures in mastocytosis: an update[J]. Ann Allergy Asthma Immunol, 2017, 119(4): 304–309. doi: 10.1016/j.anai.2017.07.022
|